161 related articles for article (PubMed ID: 21990143)
21. Selective nitros(yl)ation induced in vivo by a nitric oxide-donating cyclooxygenase-2 inhibitor: a NObonomic analysis.
Dhawan V; Schwalb DJ; Shumway MJ; Warren MC; Wexler RS; Zemtseva IS; Zifcak BM; Janero DR
Free Radic Biol Med; 2005 Nov; 39(9):1191-207. PubMed ID: 16214035
[TBL] [Abstract][Full Text] [Related]
22. Participation of the NO-cyclic GMP pathway in rofecoxib-induced antinociception.
Déciga-Campos M; López-Muñoz FJ
Proc West Pharmacol Soc; 2003; 46():165-7. PubMed ID: 14699919
[No Abstract] [Full Text] [Related]
23. Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats.
Dudhgaonkar SP; Tandan SK; Kumar D; Raviprakash V; Kataria M
Inflammopharmacology; 2007 Oct; 15(5):188-95. PubMed ID: 17943250
[TBL] [Abstract][Full Text] [Related]
24. Racemic and chiral sulfoxides as potential prodrugs of 4-pyrone COX-2 inhibitors.
Caturla F; Amat M; Reinoso RF; Calaf E; Warrellow G
Bioorg Med Chem Lett; 2006 Jul; 16(13):3605-8. PubMed ID: 16647258
[TBL] [Abstract][Full Text] [Related]
25. Novel (E)-2-(aryl)-3-(4-methanesulfonylphenyl)acrylic ester prodrugs possessing a diazen-1-ium-1,2-diolate moiety: design, synthesis, cyclooxygenase inhibition, and nitric oxide release studies.
Abdellatif KR; Dong Y; Chen QH; Chowdhury MA; Knaus EE
Bioorg Med Chem; 2007 Nov; 15(21):6796-801. PubMed ID: 17764958
[TBL] [Abstract][Full Text] [Related]
26. Dinitroglyceryl and diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of aspirin, indomethacin and ibuprofen: synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez CA; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2009 Jun; 19(11):3014-8. PubMed ID: 19419861
[TBL] [Abstract][Full Text] [Related]
27. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
Velázquez C; Praveen Rao PN; Knaus EE
J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
[TBL] [Abstract][Full Text] [Related]
28. Acyclic triaryl olefins possessing a sulfohydroxamic acid pharmacophore: synthesis, nitric oxide/nitroxyl release, cyclooxygenase inhibition, and anti-inflammatory studies.
Huang Z; Velázquez C; Abdellatif K; Chowdhury M; Jain S; Reisz J; Dumond J; King SB; Knaus E
Org Biomol Chem; 2010 Sep; 8(18):4124-30. PubMed ID: 20664853
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and anti-inflammatory activity of a series of N-substituted naproxen glycolamides: nitric oxide-donor naproxen prodrugs.
Ranatunge RR; Augustyniak ME; Dhawan V; Ellis JL; Garvey DS; Janero DR; Letts LG; Richardson SK; Shumway MJ; Trocha AM; Young DV; Zemtseva IS
Bioorg Med Chem; 2006 Apr; 14(8):2589-99. PubMed ID: 16356728
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
[TBL] [Abstract][Full Text] [Related]
31. A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis.
Consalvi S; Poce G; Ragno R; Sabatino M; La Motta C; Sartini S; Calderone V; Martelli A; Ghelardini C; Di Cesare Mannelli L; Biava M
ChemMedChem; 2016 Aug; 11(16):1804-11. PubMed ID: 27229194
[TBL] [Abstract][Full Text] [Related]
32. NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties.
Chegaev K; Lazzarato L; Tosco P; Cena C; Marini E; Rolando B; Carrupt PA; Fruttero R; Gasco A
J Med Chem; 2007 Apr; 50(7):1449-57. PubMed ID: 17335184
[TBL] [Abstract][Full Text] [Related]
33. One-Step Transformation from Rofecoxib to a COX-2 NIR Probe for Human Cancer Tissue/Organoid Targeted Bioimaging.
Xie L; Li R; Zheng B; Xie Z; Fang X; Dai T; Wang X; Li L; Wang L; Cuny GD; Eriksen J; Tu D; Chen Z; Wang X; Chen X; Hu M
ACS Appl Bio Mater; 2021 Mar; 4(3):2723-2731. PubMed ID: 35014311
[TBL] [Abstract][Full Text] [Related]
34. Sulfonamido, azidosulfonyl and N-acetylsulfonamido analogues of rofecoxib: 4-[4-(N-acetylsulfonamido)phenyl]-3-(4-methanesulfonylphenyl)-2(5H)furanone is a potent and selective cyclooxygenase-2 inhibitor.
Zarghi A; Praveen Rao PN; Knaus EE
Bioorg Med Chem Lett; 2004 Apr; 14(8):1957-60. PubMed ID: 15050636
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, anti-inflammatory activity, and in vitro antitumor effect of a novel class of cyclooxygenase inhibitors: 4-(aryloyl)phenyl methyl sulfones.
Harrak Y; Casula G; Basset J; Rosell G; Plescia S; Raffa D; Cusimano MG; Pouplana R; Pujol MD
J Med Chem; 2010 Sep; 53(18):6560-71. PubMed ID: 20804197
[TBL] [Abstract][Full Text] [Related]
36. Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.
Becker DP; Barta TE; Bedell LJ; Boehm TL; Bond BR; Carroll J; Carron CP; Decrescenzo GA; Easton AM; Freskos JN; Funckes-Shippy CL; Heron M; Hockerman S; Howard CP; Kiefer JR; Li MH; Mathis KJ; McDonald JJ; Mehta PP; Munie GE; Sunyer T; Swearingen CA; Villamil CI; Welsch D; Williams JM; Yu Y; Yao J
J Med Chem; 2010 Sep; 53(18):6653-80. PubMed ID: 20726512
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and biological evaluation of linear 1-(4-, 3- or 2-methylsulfonylphenyl)-2-phenylacetylenes: a novel class of cyclooxygenase-2 inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Dec; 13(23):6425-34. PubMed ID: 16099663
[TBL] [Abstract][Full Text] [Related]
39. Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells.
Buzharevski A; Paskaš S; Sárosi MB; Laube M; Lönnecke P; Neumann W; Murganić B; Mijatović S; Maksimović-Ivanić D; Pietzsch J; Hey-Hawkins E
Sci Rep; 2020 Mar; 10(1):4827. PubMed ID: 32179835
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R
Bioorg Med Chem; 2010 Aug; 18(16):5855-60. PubMed ID: 20650641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
